1. A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen–UVA photochemical treatment. Issue 4 (15th May 2015) Authors: Knutson, F.; Osselaer, J.; Pierelli, L.; Lozano, M.; Cid, J.; Tardivel, R.; Garraud, O.; Hervig, T.; Domanovic, D.; Cukjati, M.; Gudmundson, S.; Hjalmarsdottir, I. B.; Castrillo, A.; Gonzalez, R.; Brihante, D.; Santos, M.; Schlenke, P.; Elliott, A.; Lin, J.‐S.; Tappe, D. Journal: Vox sanguinis Issue: Volume 109:Issue 4(2015) Page Start: 343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A regional haemovigilance retrospective study of four types of therapeutic plasma in a ten‐year survey period in France. Issue 4 (7th January 2013) Authors: Bost, V.; Odent‐Malaure, H.; Chavarin, P.; Benamara, H.; Fabrigli, P.; Garraud, O. Journal: Vox sanguinis Issue: Volume 104:Issue 4(2013) Page Start: 337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Amotosalen‐HCl‐UVA pathogen reduction does not alter poststorage metabolism of soluble CD40 ligand, Ox40 ligand and interkeukin‐27, the cytokines that generally associate with serious adverse events. Issue 2 (21st October 2014) Authors: Hamzeh‐Cognasse, H.; Laradi, S.; Osselaer, J. C.; Cognasse, F.; Garraud, O. Journal: Vox sanguinis Issue: Volume 108:Issue 2(2015) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bloodletting for non‐medical reasons: what about safety and quality?. Issue 6 (24th August 2015) Authors: Garraud, O.; Tissot, J.‐D. Journal: Transfusion medicine Issue: Volume 25:Issue 6(2015) Page Start: 424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Education in transfusion medicine for medical students and doctors. Issue 3 (14th February 2013) Authors: Panzer, S.; Engelbrecht, S.; Cole‐Sinclair, M. F.; Wood, E. M.; Wendel, S.; Biagini, S.; Zhu, Z.; Lefrère, J.‐J.; Andreu, G.; Zunino, T.; Cabaud, J.‐J.; Rouger, P.; Garraud, O.; Janetzko, K.; Müller‐Steinhardt, M.; van der Burg, P.; Brand, A.; Agarwal, P.; Triyono, T.; Gharehbaghian, A. Journal: Vox sanguinis Issue: Volume 104:Issue 3(2013) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. How can non‐nucleated platelets be so smart?. (16th February 2016) Authors: Cognasse, F.; Garraud, O.; Pozzetto, B.; Laradi, S.; Hamzeh‐Cognasse, H. Journal: Journal of thrombosis and haemostasis Issue: Volume 14:Number 4(2016:Apr.) Page Start: 794 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Independent evaluation of tolerance of therapeutic plasma inactivated by amotosalen‐HCl–UVA (Intercept™) over a 5‐year period of extensive delivery. Issue 4 (29th May 2015) Authors: Bost, V.; Chavarin, P.; Boussoulade, F.; Fabrigli, P.; Chabre, C.; Benamara, H.; Odent‐Malaure, H.; Legrand, D.; Cognasse, F.; Garraud, O. Journal: Vox sanguinis Issue: Volume 109:Issue 4(2015) Page Start: 414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Modelling and simulation of blood collection systems: improvement of human resources allocation for better cost‐effectiveness and reduction of candidate donor abandonment. Issue 3 (7th December 2012) Authors: Alfonso, E.; Xie, X.; Augusto, V.; Garraud, O. Journal: Vox sanguinis Issue: Volume 104:Issue 3(2013) Page Start: 225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Paths to Understand and to Limit Inflammation in Transfusions. (January 2014) Authors: Garraud, O.; Hamzeh-Cognasse, H.; Laradi, S.; Cognasse, F. Journal: European journal of inflammation Issue: Volume 12:Number 1(2014) Page Start: 191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The complexity of setting up clinical trials for the transfusion support of myelodysplastic syndromes: How to best serve the patients' interests?. (April 2020) Authors: Garraud, O. Journal: Transfusion and apheresis science Issue: Volume 59:Number 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗